Connect with us

Cannabis News

New Politico Pro Newsletter Will Focus on Cannabis Regulation and Policy

Ella Hughes

Published

on

New Politico Pro Newsletter Will Focus on Cannabis Regulation and Policy
  • The newsletter will report on the cannabis sector with a serious, rather than friendly, tone.
  • The subscription to the newsletter will be free until September 30th.

One of the biggest problems with cannabis today is the lack of information readily circulating to the public. Politico Pro is trying to fix this problem by developing the first national policy outlet, including a cannabis team, according to reports from Washingtonian. The new vertical published a preview of the newsletter on Monday, and the public will be able to access this newsletter at no cost until the end of September.

Paul Demko, the editor for the cannabis section, commented,

“It’s a heavily regulated industry and a very rapidly changing one and it also sort of intersects with every policy area that Politico already covers. We also see a void in the media treating this like a multibillion-dollar, heavily regulated industry rather than an excuse to make weed jokes.”

The majority of the news in the cannabis sector has been covered by publications that focus on marijuana, like Marijuana Business Daily. So far, no other national policy publication has assigned a team that deals with the growing industry. Considering that the Politico Pro subscription service already has over 27,000 users, the number of people now able to learn about the changing policies in the cannabis industry is substantial.

Demko formerly has reported as a healthcare journalist. However, his move to reporting on the cannabis sector is joined by Natalie Fertig and Mona Zhang, a federal cannabis policy reporter and state cannabis policy reporter, respectively. Fertig has been a writer on cannabis policy for both Politico Magazine and Rolling Stone. Zhang, however, developed Word on the Trees, which is a daily newsletter on cannabis. She has also had bylines featured in Outline and Forbes.

Fertig stated, “It’s the ultimate policy job because it’s completely new. It’s a fruition of covering things that already existed in politics and now moving into something that doesn’t exist. It’s a new challenge.”

One of the big issues on this coverage is the fact that cannabis is federally illegal right now, despite 11 states having legalized both recreational and medical use. Along with the work of Fertig and Zhang, the network of state bureaus involved with Politico and Canada will be contributing to the reporting found on the cannabis sector.

Cannabis is being approached with a serious attitude, rather than the playful or conversational tone that other publications are taking. After all, it is a federal publication, and they plan to write about cannabis in a respectful way. Fertig explained,

“It’s the first major national new organization to create a full cannabis team and I think that’s a really amazing opportunity. We’re going to be doing some stuff that no one else is doing and we have the resources to do that.”

Ella D. Hughes’ input strengthens the legal presence at TOC with her litigator nature and fondness with fitness and adamant cooking skills. During her undergraduate study, she dove deep into diverse fields of psychology, theater, evolutionary biology, psychopharmacology, and romance languages. After being admitted to the bar, TOC is leaning on Ella to help cover the rapidly evolving cannabis and hemp industries for legal insights and regulatory law feedback.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

Follow Times of CBD News

popular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD.com is the most active daily cannabis news publication online inviting all readers to come for the headlines and stay for the insights. The primary focus is on curating latest CBD news updates, marijuana market movements and researched hemp-based product user guides. While everything is here for educational, informational purposes only, quality is always the priority and fact checking sources with industry-leading accuracy in reporting is at the top of the list of this emerging, innovative industry.

Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

Got news? Email us cont[email protected]

Trending Cannabis News

Advertisement